Selected research
Industry Research
Home Parenteral Nutrition (HPN) Industry Research Report 2026
Market perspective
The global Home Parenteral Nutrition (HPN) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Home Parenteral Nutrition (HPN) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Home Parenteral Nutrition (HPN) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Home Parenteral Nutrition (HPN) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Home Parenteral Nutrition (HPN) include B. Braun Melsungen, Grifols International, Otsuka Pharmaceutical, Sichuan Kelun Pharmaceutical, Teva Pharmaceutical, Baxter, Fresenius Kabi, Pfizer and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Home Parenteral Nutrition (HPN) market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Home Parenteral Nutrition (HPN) Market by Company
B. Braun Melsungen
Grifols International
Otsuka Pharmaceutical
Sichuan Kelun Pharmaceutical
Teva Pharmaceutical
Baxter
Fresenius Kabi
Pfizer
Takeda
Home Parenteral Nutrition (HPN) Segment by Type
Parenteral Lipid Emulsion
Single Dose Amino Acid Solution
Carbohydrates
Trace Elements
Vitamins and Minerals
Home Parenteral Nutrition (HPN) Segment by Application
Neonates
Chronic Disease Patients
Geriatrics
Home Parenteral Nutrition (HPN) Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home Parenteral Nutrition (HPN) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Home Parenteral Nutrition (HPN) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home Parenteral Nutrition (HPN).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Home Parenteral Nutrition (HPN) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Home Parenteral Nutrition (HPN) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Home Parenteral Nutrition (HPN) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Parenteral Lipid Emulsion
- Single Dose Amino Acid Solution
- Carbohydrates
- Trace Elements
- Vitamins and Minerals
Applications
- Neonates
- Chronic Disease Patients
- Geriatrics
Companies covered
- B. Braun Melsungen
- Grifols International
- Otsuka Pharmaceutical
- Sichuan Kelun Pharmaceutical
- Teva Pharmaceutical
- Baxter
- Fresenius Kabi
- Pfizer
- Takeda
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Home Parenteral Nutrition (HPN) Market Size (2021-2032)
- 2.2.2 Global Home Parenteral Nutrition (HPN) Sales (2021-2032)
- 2.2.3 Global Home Parenteral Nutrition (HPN) Market Average Price (2021-2032)
- 2.3 Home Parenteral Nutrition (HPN) by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Parenteral Lipid Emulsion
- 2.3.3 Single Dose Amino Acid Solution
- 2.3.4 Carbohydrates
- 2.3.5 Trace Elements
- 2.3.6 Vitamins and Minerals
- 2.4 Home Parenteral Nutrition (HPN) by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Neonates
- 2.4.3 Chronic Disease Patients
- 2.4.4 Geriatrics
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Home Parenteral Nutrition (HPN) Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Home Parenteral Nutrition (HPN) Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Home Parenteral Nutrition (HPN) Revenue of Manufacturers (2021-2026)
- 3.4 Global Home Parenteral Nutrition (HPN) Average Price by Manufacturers (2021-2026)
- 3.5 Global Home Parenteral Nutrition (HPN) Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Home Parenteral Nutrition (HPN), Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Home Parenteral Nutrition (HPN), Product Type & Application
- 3.8 Global Manufacturers of Home Parenteral Nutrition (HPN), Established Date
- 3.9 Global Home Parenteral Nutrition (HPN) Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 B. Braun Melsungen
- 4.1.1 B. Braun Melsungen Company Information
- 4.1.2 B. Braun Melsungen Business Overview
- 4.1.3 B. Braun Melsungen Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 B. Braun Melsungen Home Parenteral Nutrition (HPN) Product Portfolio
- 4.1.5 B. Braun Melsungen Recent Developments
- 4.2 Grifols International
- 4.2.1 Grifols International Company Information
- 4.2.2 Grifols International Business Overview
- 4.2.3 Grifols International Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Grifols International Home Parenteral Nutrition (HPN) Product Portfolio
- 4.2.5 Grifols International Recent Developments
- 4.3 Otsuka Pharmaceutical
- 4.3.1 Otsuka Pharmaceutical Company Information
- 4.3.2 Otsuka Pharmaceutical Business Overview
- 4.3.3 Otsuka Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Otsuka Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
- 4.3.5 Otsuka Pharmaceutical Recent Developments
- 4.4 Sichuan Kelun Pharmaceutical
- 4.4.1 Sichuan Kelun Pharmaceutical Company Information
- 4.4.2 Sichuan Kelun Pharmaceutical Business Overview
- 4.4.3 Sichuan Kelun Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Sichuan Kelun Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
- 4.4.5 Sichuan Kelun Pharmaceutical Recent Developments
- 4.5 Teva Pharmaceutical
- 4.5.1 Teva Pharmaceutical Company Information
- 4.5.2 Teva Pharmaceutical Business Overview
- 4.5.3 Teva Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Teva Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
- 4.5.5 Teva Pharmaceutical Recent Developments
- 4.6 Baxter
- 4.6.1 Baxter Company Information
- 4.6.2 Baxter Business Overview
- 4.6.3 Baxter Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Baxter Home Parenteral Nutrition (HPN) Product Portfolio
- 4.6.5 Baxter Recent Developments
- 4.7 Fresenius Kabi
- 4.7.1 Fresenius Kabi Company Information
- 4.7.2 Fresenius Kabi Business Overview
- 4.7.3 Fresenius Kabi Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Fresenius Kabi Home Parenteral Nutrition (HPN) Product Portfolio
- 4.7.5 Fresenius Kabi Recent Developments
- 4.8 Pfizer
- 4.8.1 Pfizer Company Information
- 4.8.2 Pfizer Business Overview
- 4.8.3 Pfizer Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Pfizer Home Parenteral Nutrition (HPN) Product Portfolio
- 4.8.5 Pfizer Recent Developments
- 4.9 Takeda
- 4.9.1 Takeda Company Information
- 4.9.2 Takeda Business Overview
- 4.9.3 Takeda Home Parenteral Nutrition (HPN) Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Takeda Home Parenteral Nutrition (HPN) Product Portfolio
- 4.9.5 Takeda Recent Developments
5 Global Home Parenteral Nutrition (HPN) Market Scenario by Region
- 5.1 Global Home Parenteral Nutrition (HPN) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Home Parenteral Nutrition (HPN) Sales by Region: 2021-2032
- 5.2.1 Global Home Parenteral Nutrition (HPN) Sales by Region: 2021-2026
- 5.2.2 Global Home Parenteral Nutrition (HPN) Sales by Region: 2027-2032
- 5.3 Global Home Parenteral Nutrition (HPN) Revenue by Region: 2021-2032
- 5.3.1 Global Home Parenteral Nutrition (HPN) Revenue by Region: 2021-2026
- 5.3.2 Global Home Parenteral Nutrition (HPN) Revenue by Region: 2027-2032
- 5.4 North America Home Parenteral Nutrition (HPN) Market Facts & Figures by Country
- 5.4.1 North America Home Parenteral Nutrition (HPN) Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Home Parenteral Nutrition (HPN) Sales by Country (2021-2032)
- 5.4.3 North America Home Parenteral Nutrition (HPN) Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Home Parenteral Nutrition (HPN) Market Facts & Figures by Country
- 5.5.1 Europe Home Parenteral Nutrition (HPN) Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Home Parenteral Nutrition (HPN) Sales by Country (2021-2032)
- 5.5.3 Europe Home Parenteral Nutrition (HPN) Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Home Parenteral Nutrition (HPN) Market Facts & Figures by Country
- 5.6.1 Asia Pacific Home Parenteral Nutrition (HPN) Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Home Parenteral Nutrition (HPN) Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Home Parenteral Nutrition (HPN) Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Home Parenteral Nutrition (HPN) Market Facts & Figures by Country
- 5.7.1 South America Home Parenteral Nutrition (HPN) Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Home Parenteral Nutrition (HPN) Sales by Country (2021-2032)
- 5.7.3 South America Home Parenteral Nutrition (HPN) Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Home Parenteral Nutrition (HPN) Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Home Parenteral Nutrition (HPN) Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Home Parenteral Nutrition (HPN) Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Home Parenteral Nutrition (HPN) Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Home Parenteral Nutrition (HPN) Sales by Type (2021-2032)
- 6.1.1 Global Home Parenteral Nutrition (HPN) Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Home Parenteral Nutrition (HPN) Sales Market Share by Type (2021-2032)
- 6.2 Global Home Parenteral Nutrition (HPN) Revenue by Type (2021-2032)
- 6.2.1 Global Home Parenteral Nutrition (HPN) Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Home Parenteral Nutrition (HPN) Revenue Market Share by Type (2021-2032)
- 6.3 Global Home Parenteral Nutrition (HPN) Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Home Parenteral Nutrition (HPN) Sales by Application (2021-2032)
- 7.1.1 Global Home Parenteral Nutrition (HPN) Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Home Parenteral Nutrition (HPN) Sales Market Share by Application (2021-2032)
- 7.2 Global Home Parenteral Nutrition (HPN) Revenue by Application (2021-2032)
- 7.2.1 Global Home Parenteral Nutrition (HPN) Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Home Parenteral Nutrition (HPN) Revenue Market Share by Application (2021-2032)
- 7.3 Global Home Parenteral Nutrition (HPN) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Home Parenteral Nutrition (HPN) Value Chain Analysis
- 8.1.1 Home Parenteral Nutrition (HPN) Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Home Parenteral Nutrition (HPN) Production Mode & Process
- 8.2 Home Parenteral Nutrition (HPN) Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Home Parenteral Nutrition (HPN) Distributors
- 8.2.3 Home Parenteral Nutrition (HPN) Customers
9 Global Home Parenteral Nutrition (HPN) Analyzing Market Dynamics
- 9.1 Home Parenteral Nutrition (HPN) Industry Trends
- 9.2 Home Parenteral Nutrition (HPN) Industry Drivers
- 9.3 Home Parenteral Nutrition (HPN) Industry Opportunities and Challenges
- 9.4 Home Parenteral Nutrition (HPN) Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst